SOZIO’s Post

Please see the attached note!

Told you there's loads going on this year! Have you used FIOR & GENTZ products? I'd love to learn more about them. Either shoot me a message or drop a comment! 👉Did you know: The NEURO SWING AFO is the only custom designed orthosis that matches the pathological gait of persons affected by neurological disorders with the accurate orthotic treatment providing dynamic balance and stability. Optimal adjustment to the patient’s needs is expected of a modern orthotic concept. This is the only way to ensure the realization of all goals required for an AFO. The adjustable NEURO SWING system ankle joint was developed for this purpose Almost all of the listed AFOs limit the physiological plantar flexion and make it difficult to achieve the best possible compromise of dorsiflexion effect, energy storage for the push off and heel rocker. https://lnkd.in/eK3dqfd9 #ossur #oandp #acquisition #orthotics

Want to keep up-to-date with the latest news in your industry/field? 🤔 Here's a tip that some of you might already use - Google #Alerts I want to keep on top of the latest clinical and scientific data, new product developments and mergers and acquisitions in #dryeye and #contactlenses. I have a Google Alert for both and get regular emails like the one below (you can set the frequency) keeping me informed. It will also bring up new stories in the consumer media which can be useful to be forearmed to answer patient questions. Mind you it's sometimes it's a bit behind the proverbial grapevine, like today's breaking news that Trukera Medical has just been acquired by Bausch + Lomb 😮 It's also a bit weird when you or one of your businesses is featured! Do you have any other tips to staying ahead of the curve? #stayuptodate #keepahead #stayinformed #optometry #ophthalmology

Denovo Hellas turns 3️⃣ 🎂 In July 2021, we submitted the official papers to found Denovo Hellas. Three years later, I’m here, proud of what we’ve achieved so far and excited about what lies ahead. This year, I want to celebrate the incredible team and the strong bonds we’ve built. Our journey is proof that genuine support and partnership matter most. 🙏 𝗧𝗼 𝗼𝘂𝗿 𝗮𝗺𝗮𝘇𝗶𝗻𝗴 𝘁𝗲𝗮𝗺: Your dedication, talent, and ethics have turned challenges into successful outcomes. Your spirit drives us forward and makes every day at Denovo fulfilling. 𝗧𝗼 𝗼𝘂𝗿 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗮𝗻𝗱 𝗰𝗹𝗶𝗲𝗻𝘁𝘀: Your trust and collaboration have been crucial. Thank you for believing in us and for your constant support. Here’s to another year of growth, innovation, and digitalization. Let’s develop the digital products of tomorrow together! PS: Choose your partner wisely. Whether you choose us or another partner, remember that the right partner will drive your success and support you through challenges, and this is invaluable. #appreciationpost #softwaredevelopment #customsoftwaredevelopment

We have so much to share - like how to create phishing-resistant users within your org. Reach out to me and I would be happy to arrange your own Executive Briefing at Black Hat!

Forward Progress

In our quest to bring projects "From Lab to Success", we try every day to support talented #LifeScience teams making an #impact on the development of new therapies, and we provide researchers in #Pharma & #Biotech with valuable tools to bring their therapies from the lab to the patient. A key part of this job is working with partners developing new disruptive #technologies and helping them reaching market scale. We are honored and excited to start this journey with Altis Biosystems, and can't wait to change the way #gut research, #toxicity and #absorption testing is performed. As Altis' team says "Go with your gut!" #innovation #preclinical #research #teamwork

Catailyst Regulatory Event Snippets: Drug Approval in a Country Approval in China Shanghai Kechow Pharma, Inc. China National Medical Products Administration Approval of Tunlametinib (HL-085), the first approved targeted therapy NRAS Mutated Advanced Melanoma and Previously Treated with PD-1/PD-L1 #melanoma a potential best-in-class MEK inhibitor based on positive data from the pivotal Phase 2 study #Tunlametinib is a small molecule inhibitor of Mitogen-activated protein kinase kinase (MEK) 

An Update from Catailyst's #Radiopharma Activity Tracker: Marketing Authorization Isotopia Molecular Imaging ltd #Isoprotrace®received marketing authorization in the Netherlands A single sterile vacuum - vial kit, intended for preparing multi-patient doses of Gallium (68Ga) Gozetotide (PSMA -11) within only 5 minutes, saving precious decay time in comparison to a standard synthesis.  https://lnkd.in/eWhuWnqd New Clinical Trials: Phase Ia/b Study Targeted Radionuclide Therapy in Metastatic Prostate Cancer  Castration-resistant Prostate Cancer https://lnkd.in/e758jW7N #ProstateCancer New Clinical Trials: 177Lu-PSMA, Niraparib/AA Plus Prednisone for Prostate Cancer  https://lnkd.in/eyQFSrHy New Clinical Trials: Actinium Pharmaceuticals, Inc. Iomab-ACT Targeted Radiotherapy as a conditioning therapy prior to CAR_T cell therapy; replace chemotherapy!! https://lnkd.in/e_tjpSwH Completion of Clinical Trial Nanobiotix, #NBTXR3: a novel, potentially first-in-class oncology product composed of functionalized hafnium oxide nanoparticles  #Cancer, non-small cell lung cancer, #lungcancer #nsclc

🚀 𝐍𝐨𝐯𝐨𝐧𝐞𝐬𝐢𝐬: 𝐀 𝐅𝐫𝐞𝐬𝐡 𝐒𝐭𝐚𝐫𝐭 𝐢𝐧 𝐁𝐢𝐨𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬! United as one, we’re Novonesis, your global BioSolutions partner. With 10,000 bright minds and biology’s wonders, we’re set to lead a new era. Novonesis means ‘a new beginning’ and is derived from the Greek word ‘genesis’. Watch the video below to know more about why Novonesis is our new name. #Novonesis #NewBeginnings #Biosolutions